We use cookies for a better user experience. Read our Privacy Policy

I Agree

Hypodermic Needles Market

Hypodermic Needles Market (Type: Safety Needles and Non-safety Needles; Application: Drug Delivery and Others; and End User: Hospitals, Cancer Treatment Centers, Dermatology Clinics, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

ISO Standards Benefit Syringe Manufacturers amid Ongoing COVID-19 Vaccine Campaigns

The worldwide vaccine campaign has placed the spotlight on syringes and needles. Healthcare providers are adhering to ISO (International Organization for Standardization) standards to ensure they meet internationally agreed levels of safety and quality. Companies in the hypodermic needles market are capitalizing on business opportunities with unprecedented demand for single-use needles and catheters for blood sampling.

Stakeholders in the healthcare landscape are gaining awareness pertaining to government guidelines about specific properties and requirements for sterile single-use hypodermic syringes. Manufacturers in the hypodermic needles market are maintaining robust supply chains to meet requirements for vaccine campaigns and ongoing COVID-19 cases of patients in hospitals. International standards are proving useful for syringe manufacturers to ensure they comply with World Health Organization (WHO) recommendations.

Request a sample to get extensive insights into the Hypodermic Needles Market

Precision-engineered Hypodermic Needles Deliver Increased Patient Comfort

The hypodermic needles market is predicted to reach US$ 4 Bn by the end of 2031. However, there is a lack of availability of precision-engineered needles for challenging applications in high-throughput processing environments. Terumo Pharmaceutical Solutions - a manufacturer of drug delivery devices, is taking advantage of this opportunity within a challenge to innovate in carefully crafted hypodermic needles that deliver comfort in parenteral therapies.

Companies in the hypodermic needles market are boosting their production capabilities in products that are patient-friendly and help to decrease penetration resistance. Thus, to gain a competitive edge, stakeholders are establishing flexible global sales and supply networks.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Can Needle-free Injectors Replace Hypodermic Needles?

Hypodermic needles are facing a stiff competition from needle-free injectors. The NuGen Medical Devices’ needle-free injector is being publicized for the same and are serving as cutting-edge replacements. However, needle-free injectors cannot entirely replace hypodermic needles. Hence, manufacturers in the hypodermic needles market are offering tailored solutions and expert engineering to clients and customers in order to improve patient outcomes.

Manufacturers in the hypodermic needles market are increasing the availability of precision-engineered needles and needle stick prevention technologies to excel in challenging applications and high-throughput processing environments. Companies are providing safe designs and less painful injections to ensure therapeutic success. Robust inspection, quality-assured, and controlled manufacturing of hypodermic needles is being achieved to face the competition placed by needle-free injectors.

Companies Invest in Automated Systems for Inspection, Testing Processes

Meeting ISO standards has become customary for manufacturers in the hypodermic needles market in order to meet the high standard of quality in materials and for accurately administering medications. The steady demand for syringes has compelled companies to adopt automated systems in inspection and testing processes. Optical and vision systems are being used for random sample checking during production processes.

Surface finish, visual appearance, and cleanliness are forming as important requirements in the hypodermic needles market. Manufacturers are increasing their production capacities in safety hypodermic needles that are carefully crafted to suit a clinician’s needs and assure patient comfort. Patented, reliable, hinged sheath design provides audible, visible, and tangible confirmation of safety for administration of medications.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Hypodermic Needles Market

Analysts’ Viewpoint

With the advent of the global COVID-19 vaccine campaigns, analysts at the Transparency Market Research are anticipating a possible shortage of hypodermic needles and syringes in nations with poor medical resources and infrastructure. The hypodermic needles market is predicted to expand at a favorable CAGR of ~6% during the assessment period. However, advantages such as decline in cross-contamination, increase in availability and subcutaneous delivery of medications with the help of needle-free injectors are posing a threat to the sales of hypodermic needles. Hence, manufacturers should increase the availability of precision-engineered needles and deploy proven track record of reliable supply of syringes to stay relevant, since needle-free injectors cannot entirely replace the performance and need of syringes in challenging high-throughput processing environments.

Hypodermic Needles Market: Overview

  • A hypodermic (hypo – under, dermic – the skin) needle is a hollow needle commonly used with a syringe to inject substances into the body or extract fluids from it. It could also be used to take liquid samples from the body; for instance, taking blood from a vein in venipuncture.
  • A hypodermic needle provides rapid delivery of liquids. It is used when the injected substance cannot be ingested orally, as it would not be absorbed, and with insulin, or as it would harm the liver.
  • Rise in prevalence of chronic diseases and increase in demand for vaccines are projected to drive the global hypodermic needles market

Hypodermic Needles: Market Drivers

  • Surge in cases of chronic diseases, including cancer and cardiovascular disorders, is a key driver of the global hypodermic needles market. Prevalence of chronic diseases is rising due to sedentary lifestyles, poor eating patterns, obesity, and high tobacco & alcohol consumption. According to the American Heart Association's 2019 study, cardiovascular disease (CVD) is the leading cause of death, accounting for over 17.6 million deaths in 2016. The number is expected to rise to 23.6 million by 2030.
  • Increase in demand for vaccines is another key factor to boost the growth of the global hypodermic needles market over the next few years. Moreover, rise in cases of infectious diseases contributes to the growth of the global market. Launch of the Universal Immunization Program (UIP) aimed at increased immunization coverage against vaccine preventable diseases fuels the growth of the market.

Hypodermic Needles: Market Segmentation

  • In terms of type, the global hypodermic needles market has been bifurcated into safety needles and non-safety needles
  • Based on application, the global market has been classified into drug delivery and others. The drug delivery segment has been split into chemotherapy, spinal/ epidural infusion, plastic surgery, and others.
  • In terms of end user, the global hypodermic needles market has been divided into hospitals, cancer treatment centers, dermatology clinics, and others
  • Each of the segments has been analyzed in detail for hypodermic needles trends, recent trends & developments, drivers, restraints, opportunities, and useful insights. The hypodermic needles market report provides current and future revenue (US$ Mn) for each of these segments for the period from 2017 to 2031, considering 2020 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2021 to 2031, along with market size estimations.

Regional Overview: Hypodermic Needles Market

  • In terms of region, the global hypodermic needles market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries and sub-regions.
  • North America accounted for the largest share of the global hypodermic needles market in 2020, and the trend is projected to continue during the forecast period. Growth of the hypodermic needles market in the region can be ascribed to the presence of major players, significant healthcare expenditure, early availability of new techniques, and increase in research activities across the country.
  • Asia Pacific is anticipated to gain market share during the forecast period. Product launches, acquisitions, distribution agreements, alliances, and geographical expansion by local players, especially in China and India, are expected to propel the hypodermic needles market in the region.
  • Current and future market sizes in terms of value (US$ Mn) of these regional markets and major countries have been provided in the report for the period from 2017 to 2031, along with CAGRs for the period from 2021 to 2031
  • The study also offers a list of recommendations, highlights, and useful insights of the market, which are likely to help new companies willing to enter the market and existing companies to increase market share, and in the decision-making process

Major Players

  • The report concludes with the company profiles section that includes key information about the major players in the global hypodermic needles market
  • Leading players analyzed in the report are
    • Becton
    • Dickinson and Company
    • B. Braun Melsungen AG
    • Medtronic
    • Smiths Medical
    • Cardinal Health
    • Novo Nordisk
    • Medline Industries, Inc.
    • Terumo Medical Corporation
    • Cadence Science
    • Exelint International, Co.
  • Each of these players has been profiled in the report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments

Hypodermic Needles Market – Segmentation

TMR’s study on the global hypodermic needles market includes information divided into four segments: type, application, end user, and region. Changing industry trends and other crucial market dynamics associated with these segments of the global hypodermic needles market are discussed in detail.

Type
  • Safety Needles
  • Non-safety Needles
Application
  • Drug Delivery
    • Chemotherapy
    • Spinal/Epidural Infusion
    • Plastic Surgery
    • Others
  • Others
End User
  • Hospitals
  • Cancer Treatment Centers
  • Dermatology Clinics
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Interested in this report?
Get a FREE sample now!

Get Free Sample

*Get Sample Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of hypodermic needles market?

The global hypodermic needles market was worth US$ 2.1 Bn and is projected to reach a value of US$ 4 Bn by the end of 2031

What is the anticipated CAGR of the hypodermic needles market in the forecast period?

Hypodermic needles market is anticipated to grow at a CAGR of 6% during the forecast period

Which region is expected to project the highest market share in hypodermic needles market?

North America accounted for a major share of the global hypodermic needles market

What are the key driving factors for growth of hypodermic needles market?

Hypodermic needles market is driven by rise in prevalence of chronic diseases and enforcement of legislation mandating the use of safety syringes

Who are the key players in the global hypodermic needles market?

Key players in the global hypodermic needles market include Becton, Dickinson and Company, B. Braun Melsungen AG, Medtronic, Smiths Medical, Cardinal Health, Novo Nordisk, Medline Industries, Inc., Terumo Medical Corporation, Cadence Science, and Exelint International, Co.

1. Preface

    1.1. Report Scope and Market Segmentation

    1.2. Research Highlights

2. Assumptions and Research Methodology

    2.1. Assumptions and Acronyms Used

    2.2. Research Methodology

3. Executive Summary

4. Market Overview

    4.1. Introduction

    4.2. Market Dynamics

        4.2.1. Drivers

        4.2.2. Restraints

        4.2.3. Opportunity

    4.3. Global Hypodermic needles Market Forecast

    4.4. Global Hypodermic needles Market Outlook

5. Market Outlook

    5.1. Regulatory Scenario

    5.2. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)

    5.3. Number of Epidural and Cosmetic Surgical Procedures

    5.4. Cancer Statistics

    5.5. COVID-19 Pandemic Impact on Industry (value chain and short-/ mid-/ long-term impact)

6. Global Hypodermic Needles Market Analysis, by Type

    6.1. Introduction

    6.2. Global Hypodermic Needles Market Value Share and Attractiveness Analysis, by Type

    6.3. Global Hypodermic Needles Market Forecast, by Type

        6.3.1. Safety Needles

        6.3.2. Non-safety Needles

    6.4. Global Hypodermic Needles Market Analysis, by Type

7. Global Hypodermic Needles Market Analysis, by Application

    7.1. Introduction

    7.2. Global Hypodermic Needles Market Value Share and Attractiveness Analysis, by Application

    7.3. Global Hypodermic Needles Market Forecast, by Application

        7.3.1. Drug Delivery

            7.3.1.1. Chemotherapy

            7.3.1.2. Spinal/Epidural Infusion

            7.3.1.3. Plastic Surgery

            7.3.1.4. Others

        7.3.2. Others

    7.4. Global Hypodermic Needles Market Analysis, by Application

8. Global Hypodermic Needles Market Analysis, by End-user

    8.1. Introduction

    8.2. Global Hypodermic Needles Market Value Share and Attractiveness Analysis, by End-user

    8.3. Global Hypodermic Needles Market Forecast, by End-user

        8.3.1. Hospitals

        8.3.2. Cancer Treatments Centers

        8.3.3. Dermatology Clinics

        8.3.4. Others

    8.4. Global Hypodermic Needles Market Analysis, by End-user

9. Global Hypodermic Needles Market Analysis, by Region

    9.1. Global Hypodermic Needles Market Analysis, by Region

    9.2. Global Hypodermic Needles Market Value Share Analysis, by Region

    9.3. Global Hypodermic Needles Market Forecast, by Region

        9.3.1. North America

        9.3.2. Europe

        9.3.3. Asia Pacific

        9.3.4. Latin America

        9.3.5. Middle East & Africa

10. North America Hypodermic Needles Market Analysis

    10.1. North America Hypodermic Needles Market Overview

    10.2. North America Hypodermic Needles Market Value Share and Attractiveness Analysis, by Country

    10.3. North America Hypodermic Needles Market Forecast, by Country

        10.3.1. U.S.

        10.3.2. Canada

    10.4. North America Hypodermic Needles Market Value Share and Attractiveness Analysis, by Type

    10.5. North America Hypodermic Needles Market Forecast, by Type

        10.5.1. Safety Needles

        10.5.2. Non-safety Needles

    10.6. North America Hypodermic Needles Market Value Share and Attractiveness Analysis, by Application

    10.7. North America Hypodermic Needles Market Forecast, by Application

        10.7.1. Drug Delivery

            10.7.1.1. Chemotherapy

            10.7.1.2. Spinal/Epidural Infusion

            10.7.1.3. Plastic Surgery

            10.7.1.4. Others

        10.7.2. Others

    10.8. North America Hypodermic Needles Market Value Share and Attractiveness Analysis, by End-user

    10.9. North America Hypodermic Needles Market Forecast, by End-user

        10.9.1. Hospitals

        10.9.2. Cancer Treatments Centers

        10.9.3. Dermatology Clinics

        10.9.4. Others

11. Europe Hypodermic Needles Market Analysis

    11.1. Europe Hypodermic Needles Market Overview

    11.2. Europe Hypodermic Needles Market Value Share and Attractiveness Analysis, by Country/Sub-region

    11.3. Europe Hypodermic Needles Market Forecast, by Country/Sub-region

        11.3.1. U.K.

        11.3.2. France

        11.3.3. Italy

        11.3.4. Germany

        11.3.5. Spain

        11.3.6. Rest of Europe

    11.4. Europe Hypodermic Needles Market Value Share and Attractiveness Analysis, by Type

    11.5. Europe Hypodermic Needles Market Forecast, by Type

        11.5.1. Safety Needles

        11.5.2. Non-safety Needles

    11.6. Europe Hypodermic Needles Market Value Share and Attractiveness Analysis, by Application

    11.7. Europe Hypodermic Needles Market Forecast, by Application

        11.7.1. Drug Delivery

            11.7.1.1. Chemotherapy

            11.7.1.2. Spinal/Epidural Infusion

            11.7.1.3. Plastic Surgery

            11.7.1.4. Others

        11.7.2. Others

    11.8. Europe Hypodermic Needles Market Value Share and Attractiveness Analysis, by End-user

    11.9. Europe Hypodermic Needles Market Forecast, by End-user

        11.9.1. Hospitals

        11.9.2. Cancer Treatments Centers

        11.9.3. Dermatology Clinics

        11.9.4. Others

12. Asia Pacific Hypodermic Needles Market Analysis

    12.1. Asia Pacific Hypodermic Needles Market Overview

    12.2. Asia Pacific Hypodermic Needles Market Value Share and Attractiveness Analysis, by Country/Sub-region

    12.3. Asia Pacific Hypodermic Needles Market Forecast, by Country/Sub-region

        12.3.1. Japan

        12.3.2. China

        12.3.3. India

        12.3.4. Australia & New Zealand

        12.3.5. Rest of Asia Pacific

    12.4. Asia Pacific Hypodermic Needles Market Value Share and Attractiveness Analysis, by Type

    12.5. Asia Pacific Hypodermic Needles Market Forecast, by Type

        12.5.1. Safety Needles

        12.5.2. Non-safety Needles

    12.6. Asia Pacific Hypodermic Needles Market Value Share and Attractiveness Analysis, by Application

    12.7. Asia Pacific Hypodermic Needles Market Forecast, by Application

        12.7.1. Drug Delivery

            12.7.1.1. Chemotherapy

            12.7.1.2. Spinal/Epidural Infusion

            12.7.1.3. Plastic Surgery

            12.7.1.4. Others

        12.7.2. Others

    12.8. Asia Pacific Hypodermic Needles Market Value Share and Attractiveness Analysis, by End-user

    12.9. Asia Pacific Hypodermic Needles Market Forecast, by End-user

        12.9.1. Hospitals

        12.9.2. Cancer Treatments Centers

        12.9.3. Dermatology Clinics

        12.9.4. Others

13. Latin America Hypodermic Needles Market Analysis

    13.1. Latin America Hypodermic Needles Market Overview

    13.2. Latin America Hypodermic Needles Market Value Share and Attractiveness Analysis, by Country/Sub-region

    13.3. Latin America Hypodermic Needles Market Forecast, by Country/Sub-region

        13.3.1. Brazil

        13.3.2. Mexico

        13.3.3. Rest of Latin America

    13.4. Latin America Hypodermic Needles Market Value Share and Attractiveness Analysis, by Type

    13.5. Latin America Hypodermic Needles Market Forecast, by Type

        13.5.1. Safety Needles

        13.5.2. Non-safety Needles

    13.6. Latin America Hypodermic Needles Market Value Share and Attractiveness Analysis, by Application

    13.7. Latin America Hypodermic Needles Market Forecast, by Application

        13.7.1. Drug Delivery

            13.7.1.1. Chemotherapy

            13.7.1.2. Spinal/Epidural Infusion

            13.7.1.3. Plastic Surgery

            13.7.1.4. Others

        13.7.2. Others

    13.8. Latin America Hypodermic Needles Market Value Share and Attractiveness Analysis, by End-user

    13.9. Latin America Hypodermic Needles Market Forecast, by End-user

        13.9.1. Hospitals

        13.9.2. Cancer Treatments Centers

        13.9.3. Dermatology Clinics

        13.9.4. Others

14. Middle East & Africa Hypodermic Needles Market Analysis

    14.1. Middle East & Africa Hypodermic Needles Market Overview

    14.2. Middle East & Africa Hypodermic Needles Market Value Share and Attractiveness Analysis, by Country/Sub-region

    14.3. Middle East & Africa Hypodermic Needles Market Forecast, by Country/Sub-region

        14.3.1. Brazil

        14.3.2. Mexico

        14.3.3. Rest of Middle East & Africa

    14.4. Middle East & Africa Hypodermic Needles Market Value Share and Attractiveness Analysis, by Type

    14.5. Middle East & Africa Hypodermic Needles Market Forecast, by Type

        14.5.1. Safety Needles

        14.5.2. Non-safety Needles

    14.6. Middle East & Africa Hypodermic Needles Market Value Share and Attractiveness Analysis, by Application

    14.7. Middle East & Africa Hypodermic Needles Market Forecast, by Application

        14.7.1. Drug Delivery

            14.7.1.1. Chemotherapy

            14.7.1.2. Spinal/Epidural Infusion

            14.7.1.3. Plastic Surgery

            14.7.1.4. Others

        14.7.2. Others

    14.8. Middle East & Africa Hypodermic Needles Market Value Share and Attractiveness Analysis, by End-user

    14.9. Middle East & Africa Hypodermic Needles Market Forecast, by End-user

        14.9.1. Hospitals

        14.9.2. Cancer Treatments Centers

        14.9.3. Dermatology Clinics

        14.9.4. Others

15. Competition Landscape

    15.1. Competition Matrix

    15.2. Company Profiles

        15.2.1. BD

            15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.1.2. Product Portfolio

            15.2.1.3. Financial Overview

            15.2.1.4. SWOT Analysis

            15.2.1.5. Strategic Overview

        15.2.2. B. Braun Melsungen AG

            15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.2.2. Product Portfolio

            15.2.2.3. Financial Overview

            15.2.2.4. SWOT Analysis

            15.2.2.5. Strategic Overview

        15.2.3. Medtronic

            15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.3.2. Product Portfolio

            15.2.3.3. Financial Overview

            15.2.3.4. SWOT Analysis

            15.2.3.5. Strategic Overview

        15.2.4. Cardinal Health

            15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.4.2. Product Portfolio

            15.2.4.3. Financial Overview

            15.2.4.4. SWOT Analysis

            15.2.4.5. Strategic Overview

        15.2.5. Medline Industries, Inc.

            15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.5.2. Product Portfolio

            15.2.5.3. SWOT Analysis

            15.2.5.4. Strategic Overview

        15.2.6. Smiths Medical

            15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.6.2. Product Portfolio

            15.2.6.3. SWOT Analysis

            15.2.6.4. Strategic Overview

        15.2.7. Novo Nordisk A/S

            15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.7.2. Product Portfolio

            15.2.7.3. Financial Overview

            15.2.7.4. SWOT Analysis

            15.2.7.5. Strategic Overview

        15.2.8. Terumo Corporation

            15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.8.2. Product Portfolio

            15.2.8.3. Financial Overview

            15.2.8.4. SWOT Analysis

            15.2.8.5. Strategic Overview

        15.2.9. Cadence Science, Inc.

            15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.9.2. Product Portfolio

            15.2.9.3. SWOT Analysis

            15.2.9.4. Strategic Overview

        15.2.10. EXELINT International, Co.

            15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.10.2. Product Portfolio

            15.2.10.3. SWOT Analysis

            15.2.10.4. Strategic Overview

List of Tables

Table 01: Global Hypodermic Needles Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 02: Global Hypodermic Needles Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 03: Global Hypodermic Needles Market Value (US$ Mn) Forecast, by Drug Delivery, 2017–2031

Table 04: Global Hypodermic Needles Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 05: Global Hypodermic Needles Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 06: North America Hypodermic Needles Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 07: North America Hypodermic Needles Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 08: North America Hypodermic Needles Market Value (US$ Mn) Forecast, by Drug Delivery, 2017–2031

Table 09: North America Hypodermic Needles Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 10: North America Hypodermic Needles Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 11: Europe Hypodermic Needles Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 12: Europe Hypodermic Needles Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 13: Europe Hypodermic Needles Market Value (US$ Mn) Forecast, by Drug Delivery, 2017–2031

Table 14: Europe Hypodermic Needles Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 15: Europe Hypodermic Needles Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 16: Asia Pacific Hypodermic Needles Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 17: Asia Pacific Hypodermic Needles Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 18: Asia Pacific Hypodermic Needles Market Value (US$ Mn) Forecast, by Drug Delivery, 2017–2031

Table 19: Asia Pacific Hypodermic Needles Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 20: Asia Pacific Hypodermic Needles Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 21: Latin America Hypodermic Needles Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 22: Latin America Hypodermic Needles Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 23: Latin America Hypodermic Needles Market Value (US$ Mn) Forecast, by Drug Delivery, 2017–2031

Table 24: Latin America Hypodermic Needles Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 25: Latin America Hypodermic Needles Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 26: Middle East & Africa Hypodermic Needles Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 27: Middle East & Africa Hypodermic Needles Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 28: Middle East & Africa Hypodermic Needles Market Value (US$ Mn) Forecast, by Drug Delivery, 2017–2031

Table 29: Middle East & Africa Hypodermic Needles Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 30: Middle East & Africa Hypodermic Needles Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

List of Figures

Figure 01: Global Hypodermic Needles Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Hypodermic Needles Market Value Share, by Type, 2020

Figure 03: Global Hypodermic Needles Market Value Share, by Application, 2020

Figure 04: Global Hypodermic Needles Market Value Share, by End-user, 2020

Figure 05: Global Hypodermic Needles Market Value Share Analysis, by Type, 2020 and 2031

Figure 06: Global Hypodermic Needles Market Attractiveness Analysis, by Type, 2021–2031

Figure 07: Global Hypodermic Needles Market Revenue (US$ Mn), by Safety Needles, 2017–2031

Figure 08: Global Hypodermic Needles Market Revenue (US$ Mn), by Non-safety Needles, 2017–2031

Figure 09: Global Hypodermic Needles Market Value Share Analysis, by Application, 2020 and 2031

Figure 10: Global Hypodermic Needles Market Attractiveness Analysis, by Application, 2021–2031

Figure 11: Global Hypodermic Needles Market Revenue (US$ Mn), by Drug Delivery, 2017–2031

Figure 12: Global Hypodermic Needles Market Revenue (US$ Mn), by Others, 2017–2031

Figure 13: Global Hypodermic Needles Market Value Share Analysis, by End-user, 2020 and 2031

Figure 14: Global Hypodermic Needles Market Attractiveness Analysis, by End-user, 2021–2031

Figure 15: Global Hypodermic Needles Market Revenue (US$ Mn), by Hospitals, 2017–2031

Figure 16: Global Hypodermic Needles Market Revenue (US$ Mn), by Cancer Treatment Centers, 2017–2031

Figure 17: Global Hypodermic Needles Market Revenue (US$ Mn), by Dermatology Clinics, 2017–2031

Figure 18: Global Hypodermic Needles Market Revenue (US$ Mn), by Others, 2017–2031

Figure 19: Global Hypodermic Needles Market Value Share, by Region, 2020 and 2031

Figure 20: Global Hypodermic Needles Market Attractiveness Analysis, by Region, 2021–2031

Figure 21: North America Hypodermic Needles Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 22: North America Hypodermic Needles Market Value Share (%), by Country, 2020 and 2031

Figure 23: North America Hypodermic Needles Market Attractiveness Analysis, by Country, 2021–2031

Figure 24: North America Hypodermic Needles Market Value Share Analysis, by Type, 2020 and 2031

Figure 25: North America Hypodermic Needles Market Attractiveness Analysis, by Type, 2021–2031

Figure 26: North America Hypodermic Needles Market Value Share Analysis, by Application, 2020 and 2031

Figure 27: North America Hypodermic Needles Market Attractiveness Analysis, by Application, 2021–2031

Figure 28: North America Hypodermic Needles Market Value Share Analysis, by End-user, 2020 and 2031

Figure 29: North America Hypodermic Needles Market Attractiveness Analysis, by End-user, 2021–2031

Figure 30: Europe Hypodermic Needles Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 31: Europe Hypodermic Needles Market Value Share (%), by Country/Sub-region, 2020 and 2031

Figure 32: Europe Hypodermic Needles Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 33: Europe Hypodermic Needles Market Value Share Analysis, by Type, 2020 and 2031

Figure 34: Europe Hypodermic Needles Market Attractiveness Analysis, by Type, 2021–2031

Figure 35: Europe Hypodermic Needles Market Value Share Analysis, by Application, 2020 and 2031

Figure 36: Europe Hypodermic Needles Market Attractiveness Analysis, by Application, 2021–2031

Figure 37: Europe Hypodermic Needles Market Value Share Analysis, by End-user, 2020 and 2031

Figure 38: Europe Hypodermic Needles Market Attractiveness Analysis, by End-user, 2021–2031

Figure 39: Asia Pacific Hypodermic Needles Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 40: Asia Pacific Hypodermic Needles Market Value Share (%), by Country/Sub-region, 2020 and 2031

Figure 41: Asia Pacific Hypodermic Needles Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 42: Asia Pacific Hypodermic Needles Market Value Share Analysis, by Type, 2020 and 2031

Figure 43: Asia Pacific Hypodermic Needles Market Attractiveness Analysis, by Type, 2021–2031

Figure 44: Asia Pacific Hypodermic Needles Market Value Share Analysis, by Application, 2020 and 2031

Figure 45: Asia Pacific Hypodermic Needles Market Attractiveness Analysis, by Application, 2021–2031

Figure 46: Asia Pacific Hypodermic Needles Market Value Share Analysis, by End-user, 2020 and 2031

Figure 47: Asia Pacific Hypodermic Needles Market Attractiveness Analysis, by End-user, 2021–2031

Figure 48: Latin America Hypodermic Needles Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 49: Latin America Hypodermic Needles Market Value Share (%), by Country Value Share (%), by Country, 2020 and 2031

Figure 50: Latin America Hypodermic Needles Market Attractiveness Analysis, by Country Value Share (%), by Country, 2021–2031

Figure 51: Latin America Hypodermic Needles Market Value Share Analysis, by Type, 2020 and 2031

Figure 52: Latin America Hypodermic Needles Market Attractiveness Analysis, by Type, 2021–2031

Figure 53: Latin America Hypodermic Needles Market Value Share Analysis, by Application, 2020 and 2031

Figure 54: Latin America Hypodermic Needles Market Attractiveness Analysis, by Application, 2021–2031

Figure 55: Latin America Hypodermic Needles Market Value Share Analysis, by End-user, 2020 and 2031

Figure 56: Latin America Hypodermic Needles Market Attractiveness Analysis, by End-user, 2021–2031

Figure 57: Middle East & Africa Hypodermic Needles Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 58: Middle East & Africa Hypodermic Needles Market Value Share (%), by Country Value Share (%), by Country, 2020 and 2031

Figure 59: Middle East & Africa Hypodermic Needles Market Attractiveness Analysis, by Country Value Share (%), by Country, 2021–2031

Figure 60: Middle East & Africa Hypodermic Needles Market Value Share Analysis, by Type, 2020 and 2031

Figure 61: Middle East & Africa Hypodermic Needles Market Attractiveness Analysis, by Type, 2021–2031

Figure 62: Middle East & Africa Hypodermic Needles Market Value Share Analysis, by Application, 2020 and 2031

Figure 63: Middle East & Africa Hypodermic Needles Market Attractiveness Analysis, by Application, 2021–2031

Figure 64: Middle East & Africa Hypodermic Needles Market Value Share Analysis, by End-user, 2020 and 2031

Figure 65: Middle East & Africa Hypodermic Needles Market Attractiveness Analysis, by End-user, 2021–2031

Figure 66: BD, Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 67: BD, Breakdown of Net Sales (%), by Region/Sub-region, 2020

Figure 68: BD, Breakdown of Net Sales (%), by Business Segment, 2020

Figure 69: B. Braun Melsungen AG, Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 70: B. Braun Melsungen AG, Breakdown of Net Sales (%), by Region/Sub-region, 2020

Figure 71: B. Braun Melsungen AG, Breakdown of Net Sales (%), by Business Segment, 2020

Figure 72: Medtronic, Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 73: Medtronic, Selling, General, and Administrative Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 74: Medtronic, Breakdown of Net Sales (%), by Region, 2020

Figure 75: Medtronic, Breakdown of Net Sales (%), by Business Segment, 2020

Figure 76: Cardinal Health, Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 77: Cardinal Health, Breakdown of Net Sales (%), by Business Segment, 2020

Figure 78: Cardinal Health, Breakdown of Net Sales (%), by Region, 2020

Figure 79: Novo Nordisk A/S, Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2020

Figure 80: Novo Nordisk A/S, Breakdown of Net Sales (%), by Region/Country, 2020

Figure 81: Novo Nordisk A/S, Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2020, by Business Segments

Figure 82: Novo Nordisk A/S, R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 83: Terumo Corporation, Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 84: Terumo Corporation, Breakdown of Net Sales (%), by Region/Sub-region, 2020

Figure 85: Terumo Corporation, Breakdown of Net Sales (%), by Business Segment, 2020

Transparency Market Research Plus

Get a free copy if the report you purchased is updated within 90 days

Copyright © Transparency Market Research, Inc. All Rights reserved